DESENTUM
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, they have made discoveries that allow for improved design of vaccines against common types of allergies. Their goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society.
DESENTUM
Industry:
Biotechnology Pharmaceutical
Founded:
2011-01-01
Address:
Espoo, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.desentum.fi
Total Employee:
1+
Status:
Active
Contact:
+358500512934
Email Addresses:
[email protected]
Total Funding:
17.69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Content Delivery Network Apache Euro US Privacy User Signal Mechanism YouTube Pound Sterling Japanese Yen
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Current Employees Featured
Founder
Investors List
Springvest
Springvest investment in Venture Round - Desentum
European Innovation Council
European Innovation Council investment in Grant - Desentum
Springvest
Springvest investment in Series A - Desentum
VTT Ventures
VTT Ventures investment in Series A - Desentum
Sto-Rahoitus
Sto-Rahoitus investment in Series A - Desentum
Luxembourgian ACME Investments
Luxembourgian ACME Investments investment in Series A - Desentum
Cascara Ventures
Cascara Ventures investment in Series A - Desentum
Official Site Inspections
http://www.desentum.fi
- Host name: fi-f1.seravo.net
- IP address: 95.217.114.231
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki
